文献速递乳房整形与再造

美国保险公司对非癌症乳房再造的保险覆盖全国性审查

A National Review of Insurance Coverage of Noncancerous Breast Reconstruction.
PubMed 文献 · Ann Plast Surg · 2021-01-01

该研究对102家美国保险公司(含Medicare和Medicaid)进行横断面分析,评估非癌症适应症(Poland综合征、纤维囊性乳腺病、烧伤和创伤)乳房再造的保险覆盖情况。结果显示半数保险公司对Poland综合征无政策,46%对烧伤和创伤无政策,82%对纤维囊性乳腺病无政策,且各公司对医学必要性的界定缺乏共识。

要点

  • 非癌症乳房再造的保险政策普遍缺失,纤维囊性乳腺病无政策比例最高(82%)。
  • 有政策的保险公司中,对医学必要性设定严格标准的比例因适应症而异。
  • 部分政策涵盖对侧乳房,但各公司覆盖范围不一致。

核心结论

  • 公开可得的非癌症乳房再造保险覆盖信息匮乏,美国主要保险公司对手术矫正的医学必要性缺乏共识。

研究设计与样本

  • 横断面分析,纳入102家美国保险公司(包括Medicare和Medicaid),基于州参保数据和市场份额选择。
  • 通过基于网络的搜索和电话访谈识别政策,从公开政策中提取医学必要性标准。

主要发现

  • 49%(n=50)的保险公司对Poland综合征无政策,46%(n=47)对烧伤和创伤无政策,82%(n=84)对纤维囊性乳腺病无政策。

临床怎么用

  • 临床医生在为非癌症适应症患者申请乳房再造时,需了解保险政策差异大且常无明确覆盖,应提前准备详细的医学必要性论证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast reconstruction is commonly performed for a multitude of noncancerous indications, such as correction of congenital deformities, acquired tissue disease, burns, and trauma. However, breast reconstruction for noncancerous indications is often considered cosmetic or not explicitly mentioned in insurance policies. The goal of this study was to assess variability in insurance coverage of breast reconstruction for noncancerous indications. METHODS: The authors conducted a cross-sectional analysis of 102 US insurance companies, including Medicare and Medicaid, for coverage of breast reconstruction for noncancerous indications (Poland syndrome, fibrocystic breast disease, burns and trauma). Insurance companies were selected based on their state enrollment data and market share. A Web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies. RESULTS: Half of the insurers (49%, n = 50) had no policy for Poland syndrome, 46% (n = 47) had no policy for burns and trauma, and 82% (n = 84) had no policy for fibrocystic breast disease. Fifty-two percent (n = 22) of policies providing coverage for Poland syndrome, 24% (n = 13) of policies providing coverage for burns and trauma, and 58% (n = 7) of policies providing coverage for fibrocystic breast disease had specific, stringent criteria for medical necessity. Thirty-six percent (n = 15) of policies covering Poland syndrome, 47% (n = 26) of policies covering burns and trauma, and 33% (n = 4) of policies covering fibrocystic breast disease include coverage of the contralateral breast. CONCLUSIONS: There is a paucity of publicly available information on insurance coverage of breast reconstruction for noncancerous indications and a lack of consensus between top US insurance companies on what constitutes medical necessity for surgical correction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Klein M, Ha M, Yang A, et al. A National Review of Insurance Coverage of Noncancerous Breast Reconstruction. Ann Plast Surg. 2021. PMID: 34397512. doi:10.1097/SAP.0000000000002871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。